United Therapeutics Corporation: 10-Q filed 2014-07-29
What United Therapeutics Corporation reported in its quarterly report filed 2014-07-29 (fiscal Q2 2014): 39 published measures, 112 facts as tagged in accession 0001104659-14-054116.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-07-29
- Fiscal period
- fiscal Q2 2014
- Accession
- 0001104659-14-054116 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All United Therapeutics Corporation filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 1,952,872,000 | USD | |
| At 2013-12-31 | 2,087,567,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 739,797,000 | USD | |
| At 2013-12-31 | 783,256,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 1,173,905,000 | USD | |
| At 2013-12-31 | 1,259,274,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 259,046,000 | USD | |
| At 2013-12-31 | 278,889,000 | USD | |
| At 2013-06-30 | 343,550,000 | USD | |
| At 2012-12-31 | 154,030,000 | USD |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 31,512,000 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 9,080,000 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 322,802,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 612,205,000 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 280,606,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 525,742,000 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 977,416,000 | USD | |
| At 2013-12-31 | 728,040,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 47,617,000 | shares | 91 |
| 2014-01-01 to 2014-06-30 | 49,002,000 | shares | 181 |
| 2013-04-01 to 2013-06-30 | 49,800,000 | shares | 91 |
| 2013-01-01 to 2013-06-30 | 50,003,000 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 53,252,000 | shares | 91 |
| 2014-01-01 to 2014-06-30 | 54,948,000 | shares | 181 |
| 2013-04-01 to 2013-06-30 | 52,648,000 | shares | 91 |
| 2013-01-01 to 2013-06-30 | 52,386,000 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 2.35 | USD/shares | 91 |
| 2014-01-01 to 2014-06-30 | 5.09 | USD/shares | 181 |
| 2013-04-01 to 2013-06-30 | 1.6 | USD/shares | 91 |
| 2013-01-01 to 2013-06-30 | 2.84 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 2.1 | USD/shares | 91 |
| 2014-01-01 to 2014-06-30 | 4.54 | USD/shares | 181 |
| 2013-04-01 to 2013-06-30 | 1.52 | USD/shares | 91 |
| 2013-01-01 to 2013-06-30 | 2.71 | USD/shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 61,181,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 136,873,000 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 38,655,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 67,165,000 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 477,534,000 | USD | |
| At 2013-12-31 | 464,950,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | -62,596,000 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 68,199,000 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 176,320,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 392,460,000 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 122,304,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 216,341,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 881,608,000 | USD | |
| At 2013-12-31 | 909,013,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 4,746,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 9,356,000 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 4,520,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 8,956,000 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 659,073,000 | USD | |
| At 2013-12-31 | 687,674,000 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 10,666,000 | USD | |
| At 2013-12-31 | 10,703,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 212,902,000 | USD | |
| At 2013-12-31 | 126,297,000 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 377,562,000 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 42,438,000 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 58,033,000 | USD | |
| At 2013-12-31 | 47,758,000 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 282,620,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 536,573,000 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 245,175,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 459,008,000 | USD | 181 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 68,031,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 98,246,000 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 71,365,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 142,721,000 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 39,742,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 52,190,000 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 54,617,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 105,047,000 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 47,230,528 | shares | |
| At 2013-12-31 | 50,388,140 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | -14,627,000 | USD | |
| At 2013-12-31 | -13,183,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 103,699,000 | USD | |
| At 2013-12-31 | 58,637,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 80,724,000 | USD | |
| At 2013-12-31 | 95,582,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 173,033,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 386,249,000 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 118,519,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 209,354,000 | USD | 181 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 112,867,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 247,932,000 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 79,712,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 140,031,000 | USD | 181 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 111,852,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 249,376,000 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 79,864,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 142,189,000 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 15,206,000 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 15,845,000 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 349,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 802,000 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -134,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 121,000 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -3,287,000 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -6,211,000 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -3,785,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -6,987,000 | USD | 181 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 2,727,000 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 2,775,000 | USD | 181 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 140,366,000 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 85,649,000 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 86,473,000 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 15,455,000 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 11,266,000 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 7,705,000 | USD | 181 |
Inspect the source
- Entity
- United Therapeutics Corporation / CIK 0001082554
- Captured
- 2026-09-20T05:20:46.268Z
- SEC response SHA-256
d0d5a14871c4fdbecaf0010c9b80c4651b227dba727aa3a0aedb0042bd1ae9c3
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001082554.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))